Legal Deadline Reminder
November 12, 2024 marks the impending deadline awaited by investors as Law Offices of Howard G. Smith issues a reminder about the lead plaintiff motion filing against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) trading as NASDAQ:ALLR. The lawsuit pertains to investors who acquired Allarity shares between May 17, 2022, and July 19, 2024 (the “Class Period”).
Stock Suffering and Troubling Disclosures
Recent turbulent times for Allarity stock unfolded with troubling disclosures. On February 6, 2023, Allarity bore a 3.8% stock slump following news of an SEC investigation. Later, on December 11, 2023, the market witnessed a sharp 13.4% drop as Allarity’s CEO faced termination. The storm continued on July 22, 2024, with a 2.4% decrease after the company received a Wells Notice from the SEC, causing further distress for investors.
Allegations of Misleading Statements
The legal complaint asserts that during the Class Period, Allarity made misleading statements and omitted crucial facts about its business. Allegations span overstating regulatory prospects, engaging in illicit conduct, downplaying regulatory risks, and making misleading positive statements. These actions exposed Allarity to regulatory scrutiny and precipitated reputational and financial harm.
Legal Action and Investor Rights
Investors who held Allarity securities during the Class Period have the opportunity to step forth and partake in legal action by meeting specific legal requirements before the November 12, 2024 deadline. They may engage legal counsel or choose to remain a silent member of the class action. For further inquiries or to understand the legal proceedings better, investors are invited to contact Howard G. Smith, Attorney at Law, or visit the Law Offices of Howard G. Smith’s website.
Attorney Advertising Disclaimer
This communication serves as a reminder that law offices involved in this matter may consider it as Attorney Advertising in certain jurisdictions, subject to applicable laws and ethical regulations.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20240920943282/en/
Market News and Data brought to you by Benzinga APIs